Candace Bramson

1.1k total citations
36 papers, 823 citations indexed

About

Candace Bramson is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Candace Bramson has authored 36 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Anesthesiology and Pain Medicine, 9 papers in Pharmacology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Candace Bramson's work include Pain Management and Opioid Use (11 papers), Opioid Use Disorder Treatment (9 papers) and Pain Mechanisms and Treatments (8 papers). Candace Bramson is often cited by papers focused on Pain Management and Opioid Use (11 papers), Opioid Use Disorder Treatment (9 papers) and Pain Mechanisms and Treatments (8 papers). Candace Bramson collaborates with scholars based in United States, Japan and Canada. Candace Bramson's co-authors include M. Brown, Mary Anne Nemeth, Christine R. West, Kenneth M. Verburg, C. Birbara, David Borenstein, Mike D. Smith, Nathaniel P. Katz, Alan Kivitz and Joseph Gimbel and has published in prestigious journals such as Pain, American Journal of Tropical Medicine and Hygiene and Osteoarthritis and Cartilage.

In The Last Decade

Candace Bramson

35 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candace Bramson United States 15 329 317 150 110 96 36 823
Raymond Cheung United States 22 350 1.1× 445 1.4× 62 0.4× 138 1.3× 385 4.0× 40 1.5k
Lorna Mason United Kingdom 8 289 0.9× 322 1.0× 27 0.2× 31 0.3× 106 1.1× 8 756
Ali Zandieh Iran 20 178 0.5× 43 0.1× 93 0.6× 54 0.5× 45 0.5× 51 979
Margaret Noyes Essex United States 13 82 0.2× 250 0.8× 34 0.2× 61 0.6× 51 0.5× 31 490
Yanlin Wang China 21 127 0.4× 43 0.1× 90 0.6× 120 1.1× 61 0.6× 76 1.1k
Milica Prostran Serbia 12 150 0.5× 233 0.7× 41 0.3× 34 0.3× 75 0.8× 22 626
Ioanna Vasileiou Greece 12 74 0.2× 116 0.4× 68 0.5× 57 0.5× 76 0.8× 29 641
Seyed Hesameddin Abbasi Iran 18 66 0.2× 190 0.6× 55 0.4× 77 0.7× 34 0.4× 70 1.5k
Kok‐Yuen Ho Singapore 19 395 1.2× 303 1.0× 214 1.4× 116 1.1× 726 7.6× 40 1.7k
Darcy Vavrek United States 16 232 0.7× 260 0.8× 146 1.0× 264 2.4× 10 0.1× 27 916

Countries citing papers authored by Candace Bramson

Since Specialization
Citations

This map shows the geographic impact of Candace Bramson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace Bramson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace Bramson more than expected).

Fields of papers citing papers by Candace Bramson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace Bramson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace Bramson. The network helps show where Candace Bramson may publish in the future.

Co-authorship network of co-authors of Candace Bramson

This figure shows the co-authorship network connecting the top 25 collaborators of Candace Bramson. A scholar is included among the top collaborators of Candace Bramson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace Bramson. Candace Bramson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2024). Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. European Journal of Preventive Cardiology. 31(10). 1216–1223. 8 indexed citations
2.
Furihata, Kenichi, et al.. (2023). A multi‐purpose Japanese phase I study in the global development of vupanorsen: Randomized, placebo‐controlled, single‐ascending dose study in adults. Clinical and Translational Science. 16(5). 886–897. 8 indexed citations
3.
Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2023). Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3. Journal of clinical lipidology. 18(2). e261–e268. 6 indexed citations
4.
Markman, John D., Thomas J. Schnitzer, Serge Perrot, et al.. (2022). Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial. Pain and Therapy. 11(4). 1267–1285. 4 indexed citations
5.
Malhotra, Bimal, et al.. (2015). Effects of Ethanol on the Pharmacokinetics of Extended-Release Oxycodone with Sequestered Naltrexone (ALO-02). Clinical Drug Investigation. 35(4). 267–274. 8 indexed citations
6.
Setnik, Beatrice, Candace Bramson, Almasa Bass, et al.. (2015). Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users. The Journal of Clinical Pharmacology. 55(12). 1351–1361. 17 indexed citations
7.
8.
9.
Gimbel, Joseph, Alan Kivitz, Candace Bramson, et al.. (2014). Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain. Pain. 155(9). 1793–1801. 44 indexed citations
10.
11.
Kivitz, Alan, Joseph Gimbel, Candace Bramson, et al.. (2013). Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain. 154(7). 1009–1021. 113 indexed citations
12.
Bramson, Candace, David N. Herrmann, Victor Biton, et al.. (2013). Efficacy and safety of subcutaneous tanezumab in patients with pain related to diabetic peripheral neuropathy (NCT01087203). Journal of Pain. 14(4). S68–S68. 7 indexed citations
13.
Katz, Nathaniel P., David Borenstein, C. Birbara, et al.. (2012). Response to letter by Ackermann. Pain. 153(5). 1129–1131. 2 indexed citations
14.
Misko, Thomas P., Melissa R. Radabaugh, Maureen Highkin, et al.. (2012). Characterization of nitrotyrosine as a biomarker for arthritis and joint injury. Osteoarthritis and Cartilage. 21(1). 151–156. 38 indexed citations
15.
Katz, Nathaniel P., David Borenstein, C. Birbara, et al.. (2011). Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain. 152(10). 2248–2258. 183 indexed citations
16.
Bramson, Candace, et al.. (2006). A Single‐Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 46(1). 29–36. 12 indexed citations
17.
Chung, Menger, et al.. (2006). Effect of Food on the Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination Tablet. The Journal of Clinical Pharmacology. 46(10). 1212–1216. 23 indexed citations
18.
Ouellet, Danièle, et al.. (2006). Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. British Journal of Clinical Pharmacology. 63(1). 59–66. 17 indexed citations
19.
Harris, Richard E., Joanne Jeter, Paul Chan, et al.. (2005). Using Acupressure to Modify Alertness in the Classroom: A Single-Blinded, Randomized, Cross-Over Trial. The Journal of Alternative and Complementary Medicine. 11(4). 673–679. 21 indexed citations
20.
Bramson, Candace, et al.. (2005). Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology. 45(12). 1407–1412. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond Cheung Breakdown of academic impact, for papers by Lorna Mason Breakdown of academic impact, for papers by Ali Zandieh Breakdown of academic impact, for papers by Margaret Noyes Essex Breakdown of academic impact, for papers by Yanlin Wang Breakdown of academic impact, for papers by Milica Prostran Breakdown of academic impact, for papers by Ioanna Vasileiou Breakdown of academic impact, for papers by Seyed Hesameddin Abbasi Breakdown of academic impact, for papers by Kok‐Yuen Ho Breakdown of academic impact, for papers by Darcy Vavrek
Rankless by CCL
2026